InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,022.21
(
-0.58%
)
US TECH 100
17,060.00
(
-1.07%
)
Dow Jones
37,753.31
(
-0.12%
)
Brent Oil
87.01
(
0.02%
)
Bitcoin
62,128.61
(
1.39%
)
Post# of 712
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

JerichoJackson

Send PM Follow Ignore
Followers 3
Posts 185
Boards Moderated 0
Alias Born 07/18/2012

JerichoJackson

Re: mj1234 post# 435

Thursday, 08/27/2015 10:05:46 PM

Thursday, August 27, 2015 10:05:46 PM

Post# of 712
On August 9, 2015, Pfizer’s option to obtain worldwide rights to iSONEP expired, unexercised, which resulted in the termination of the Pfizer Agreement. Consequently, all rights that Pfizer held in the iSONEP program have reverted to Lpath. Lpath has no plans for further development of iSONEP.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up